Angio-seal used as a bailout for incomplete hemostasis after dual perclose ProGlide deployment in transcatheter aortic valve implantation

Basit Öğe Kaydı
dc.authorid0000-0003-0230-6575
dc.authorid0000-0002-4281-0867
dc.authorid0000-0003-1919-3183
dc.authorid0000-0001-5825-8627
dc.authorid0000-0003-1516-1811
dc.authorid0000-0002-4951-6716
dc.contributor.authorÇakal, Beytullah
dc.contributor.authorÇakal, Sinem
dc.contributor.authorKaraca, Oğuz
dc.contributor.authorKızılırmak Yılmaz, Filiz
dc.contributor.authorGüneş, Hacı Murat
dc.contributor.authorYıldırım, Arzu
dc.contributor.authorÖzcan, Özgür Ulaş
dc.contributor.authorGüler, Yeliz
dc.contributor.authorBoztosun, Bilal
dc.date.accessioned2022-12-26T09:38:14Z
dc.date.available2022-12-26T09:38:14Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı
dc.description.abstractBackground: The failure rate of vascular closure devices remains a significant cause of major vascular complications in contemporary transcatheter aortic valve implantation practice. Methods: This research aimed to evaluate use of the Angio-Seal device in a bailout context in the setting of incomplete hemostasis following use of dual Perclose ProGlide devices in patients undergoing transfemoral transcatheter aortic valve implantation. A total of 185 patients undergoing transfemoral transcatheter aortic valve implantation with either dual Per-close ProGlide (n = 139) or a combination of dual Perclose ProGlide and Angio-Seal (n = 46) were retrospectively analyzed. The baseline, procedural characteristics, and all outcomes (defined according to Valve Academic Research Consortium-2 criteria) were compared. Results: No significant differences were seen between the dual Perclose ProGlide vs dual Perclose ProGlide+Angio-Seal groups with regard to the in-hospital Valve Academic Research Consortium-2 primary end points of major vascular complications (n = 13 [9.4%] vs n = 2 [4.3%]; P =.36), minor vascular complications (n = 13 [9.4%] vs n = 8 [14.7%]; P =.14), major bleeding (n = 16 [11.5%] vs n = 2 [4.3%]; P =.25), and minor bleeding (n = 9 [6.5%] vs n = 5 [10.9%]; P =.34), with higher rates of hematoma in the dual Perclose ProGlide+Angio-Seal group (n = 4 [2.9%] vs n = 5 [10.9%]; P =.044). Conclusion: Finding from the current study suggest that adjunctive Angio-Seal deployment may be feasible and safe, especially in patients with incomplete hemostasis following dual Perclose ProGlide use, and can be an optimal “bailout” procedure. (Tex Heart Inst J. 2022;49(6):e217684).
dc.identifier.citationÇakal, B., Çakal, S., Karaca, O., Kızılırmak Yılmaz, F., Güneş, H. M., Yıldırım, A. ... Boztosun, B. (2022). Angio-seal used as a bailout for incomplete hemostasis after dual perclose ProGlide deployment in transcatheter aortic valve implantation. Texas Heart Institute Journal, 49(6). https://doi.org/10.14503/THIJ-21-7684
dc.identifier.doi10.14503/THIJ-21-7684
dc.identifier.issn0730-2347
dc.identifier.issue6
dc.identifier.pmid36515932
dc.identifier.scopus2-s2.0-85144066677
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.14503/THIJ-21-7684
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10183
dc.identifier.volume49
dc.identifier.wos000899359200001en_US
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorÇakal, Beytullah
dc.institutionauthorKaraca, Oğuz
dc.institutionauthorKızılırmak Yılmaz, Filiz
dc.institutionauthorGüneş, Hacı Murat
dc.institutionauthorYıldırım, Arzu
dc.institutionauthorÖzcan, Özgür Ulaş
dc.institutionauthorGüler, Yeliz
dc.institutionauthorBoztosun, Bilal
dc.language.isoen
dc.publisherTexas Heart Institute
dc.relation.ispartofTexas Heart Institute Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPeripheral Artery Diseases
dc.subjectHemostasis
dc.subjectVascular Access Device
dc.titleAngio-seal used as a bailout for incomplete hemostasis after dual perclose ProGlide deployment in transcatheter aortic valve implantation
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Cakal-Beytullah-2022.pdf
Boyut:
251.5 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu